Faculty Labs and Research

The aim of Ban-An Khaw’s research is to develop new approaches for diagnosis of various cardiovascular diseases and cancer, and to use them to further the understanding of the pathogenesis of these disorders to formulate novel therapies.

Research in the Makowski Lab focuses on Image and signal processing as applied to biophysical data designed to answer fundamental questions about the molecular basis of living systems, and progression of Alzheimer’s Disease.

Chiara Bellini studies diseases of the cardiovascular system and the effects of cellmediated growth and remodeling processes on tissue and organ mechanics.

Guohao Dai’s research focuses on 3-D bioprinting technology, stem cells technology, and vascular bioengineering.

Shashi Murthy’s research focuses on microfluidic isolation of stem and progenitor cells, point-of-care diagnostics, cell surface phenomena during microfluidic flow, nanoscale probes for cell stimulation, and biopassive/bioactive coatings for neurological implants.

Harikrishnan Parameswaran’s research focuses on cell-extracellular matrix interactions, force transmission in multicellular ensembles, asthma, pulmonary physiology.

Jeffrey Ruberti’s research focuses on tissue engineering of load-bearing matrix (bone, cornea), bioreactor design, multi-scale mechanobiochemistry, statistical mechanics, energetics microscopy, high-resolution imaging, and biopolymer self-assembly.

Research in the Stubbins Lab focuses on environmental chemistry, geochemistry, the carbon cycle, freshwater, coastal and ocean biogeochemistry, feedbacks between natural biogeochemical cycles and climate change, permafrost, black carbon, and aquatic microplastics.

Yunrong Chai’s lab is interested in understanding fundamental mechanisms controlling bacterial biofilm formation and the role of beneficial biofilms in bacteria-host interactions. They are also interested in inhibitory mechanisms targeting key processes during bacterial biofilm development.

The Geisinger Lab investigates the molecular basis of antibiotic resistance and disease development in infections with hospital-acquired pathogens.

Oyinda Oyelaran is the co-PI of the Chemistry and Chemical Biology department’s NSF-REU site program.

Vladimir Torchilin’s lab is conducting research on long-circulating and targeted pharmaceutical carriers for drugs and diagnostics in a variety of in vitro and in vivo models.